Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2021 December;62(6) > The Journal of Cardiovascular Surgery 2021 December;62(6):625-31



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



The Journal of Cardiovascular Surgery 2021 December;62(6):625-31

DOI: 10.23736/S0021-9509.21.11608-8


language: English

Perceval S valve empire: healing the Achilles’ heel of sutureless aortic valves

Nikolaos A. PAPAKONSTANTINOU 1 , Nikolaos G. BAIKOUSSIS 2, Panagiotis DEDEILIAS 3

1 Third Department of Cardiac Surgery, Onassis Cardiac Surgery Center, Kallithea, Athens, Greece; 2 Department of Cardiac Surgery, General Hospital of Athens Ippokrateio, Athens, Greece; 3 Department of Cardiothoracic Surgery, General Hospital of Athens “Evangelismos,” Athens, Greece

Aortic valve replacement is the treatment of choice concerning aortic valve disease. Excellent short- and long-term clinical results are reported. Patients referred for aortic valve replacement are getting older and older, so bioprosthetic valves play a more central role worldwide. However, patient comorbidities are also increased more often rendering patients unsuitable for open conventional aortic valve replacement. As a result, transcatheter aortic valve implantation has become the treatment of choice in patients at very high surgical risk. However, the percutaneous technique is related to major disadvantages provided that the diseased native valve is left in place. Its durability is also uncertain. More recently, sutureless Perceval S valve bioprosthesis has gained ground in the field of aortic stenosis therapy filling the gap between conventional aortic valve replacement and transcatheter approach. Excellent hemodynamic and clinical results are reported. Its deployment is performed under direct view and ischemic and overall operative times are significantly decreased. Five-year follow-up results are also optimal. However, the “Achilles’ heel” of sutureless technology is increased rates of postoperative permanent pacemaker implantation requirement compared to conventional approach. The incidence of this complication varies in literature. Patient-related factors such as preoperative conduction disorders, older age and short membranous septum are predictors of postoperative pacemaker requirement. However, several technical modifications regarding manufacturer recommendations can be adopted to mitigate this complication. Appropriate annular decalcification, higher guiding sutures placement, reduced balloon pressure and duration and avoiding of oversizing can contribute to prevent from this complication.

KEY WORDS: Transcatheter aortic valve replacement; Sutureless surgical procedures; Pacemaker, artificial

top of page